Journal
CANCER BIOLOGY & THERAPY
Volume 5, Issue 7, Pages 827-832Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/cbt.5.7.2838
Keywords
CXCL12; TTP; PDGFR-beta; PDGF-B; nestin; MVD; oligoastrocytoma; oligodendroglioma
Categories
Ask authors/readers for more resources
Both clinical and biological features have been reported as prognostic factors in low-grade gliomas. Among these, histotype, tumor size, enhancement, age and genetic pattern. Microvessel density (MVD) has been correlated to clinical outcome in astrocytomas, but its impact in oligodendrogliomas and mixed tumors is not sure. The pro-angiogenic chemokine stromal cell-derived factor (SDF-1 /CXCL12) and its receptor CXC chemokine receptor 4 (CXCR4) have been described in low-grade gliomas, with a correlation between CXCL12 expression and shorter time to progression (TTP). The intermediate filament Nestin is expressed in proliferating vessels. Platelet-derived growth factor B (PDGF-B) and its receptor PDGFR-P are also involved in angiogenesis and malignant progression in gliomas.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available